Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-13.3%
operating margin TTM
-13.94%
revenue TTM
122.35 Million
revenue per share TTM
4.7$
valuation ratios | |
|---|---|
| pe ratio | -2.97 |
| peg ratio | 0.10 |
| price to book ratio | 0.36 |
| price to sales ratio | 0.40 |
| enterprise value multiple | -1.05 |
| price fair value | 0.36 |
profitability ratios | |
|---|---|
| gross profit margin | 42.13% |
| operating profit margin | -13.94% |
| pretax profit margin | -13.7% |
| net profit margin | -13.3% |
| return on assets | -7.37% |
| return on equity | -11.82% |
| return on capital employed | -8.24% |
liquidity ratios | |
|---|---|
| current ratio | 4.42 |
| quick ratio | 4.06 |
| cash ratio | 1.73 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 25.23 |
| operating cycle | 107.15 |
| days of payables outstanding | 21.90 |
| cash conversion cycle | 85.25 |
| receivables turnover | 4.46 |
| payables turnover | 16.67 |
| inventory turnover | 14.47 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.30 |
| debt equity ratio | 0.49 |
| long term debt to capitalization | 0.29 |
| total debt to capitalization | 0.33 |
| interest coverage | -38.06 |
| cash flow to debt ratio | 0.05 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.20 |
| cash per share | 5.66 |
| operating cash flow per share | 0.87 |
| free cash flow operating cash flow ratio | -0.23 |
| cash flow coverage ratios | 0.05 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.82 |
Frequently Asked Questions
When was the last time NeoGenomics, Inc. (NASDAQ:NEO) reported earnings?
NeoGenomics, Inc. (NEO) published its most recent earnings results on 28-04-2026.
What is NeoGenomics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. NeoGenomics, Inc. (NASDAQ:NEO)'s trailing twelve months ROE is -11.82%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. NeoGenomics, Inc. (NEO) currently has a ROA of -7.37%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did NEO's net profit margin stand at?
NEO reported a profit margin of -13.3% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is NEO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.42 in the most recent quarter. The quick ratio stood at 4.06, with a Debt/Eq ratio of 0.49.